Skip to content

Evaluation of the effect of therapies to support facial disorders on physical, psychological, social and sleep-related aspects

Evaluation of the effect of support therapies for Temporomandibular Disorders (TMD) about physical, psychosocial and related to sleep

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-7xx7g7
Enrollment
Unknown
Registered
2020-03-30
Start date
2018-12-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Dysfunction Syndrome, Pathological conditions, signs and symptoms

Interventions

Participants will be randomly assigned to 5 parallel intervention groups in a 1: 1: 1: 1: 1 ratio. Group I being treated through counseling, group II by craniopuncture, group III by low intensity lase
Radiation
Behavioural
Other
E02.190.044
E02.190.599
F02.784.176
E02.594.540

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with a positive diagnosis for TMD obtained through axis I of the RDC / TMD were included; those who underwent last treatment for TMD with a minimum interval of 3 (three) months; individuals with reports of pain in the orofacial region in the last 3 (three) months; patients aged 18 to 65 years.

Exclusion criteria

Exclusion criteria: Individuals with impaired cognitive ability who were unable to understand the questions in the questionnaires were excluded; those with a history of head trauma that is related to the etiology of orofacial pain and that can confuse the diagnosis of TMD; those with headaches or intracranial disorders; individuals who have used medications in the past 3 months that interfere with sleep quality such as muscle relaxants, anticonvulsants, antidepressants and anxiolytics; patients using medication to treat TMD or muscle pain; those who had other causes of orofacial pain such as caries, periodontal diseases, neuropathies and fibromyalgia; who had an insurmountable fear of a needle or bleeding disorders (only for the craniopuncture group).

Design outcomes

Primary

MeasureTime frame
The therapies (counseling, craniopuncture, low-intensity laser therapy associated with craniopuncture, biofeedback and manual therapy) will improve the functional, physical, psychological aspects, and related to sleep and quality of life in patients diagnosed with TMD. the data will be gathered in a database created in the program Statistical Package for the Social Science (SPSS) 22.0. Descriptive analysis of the data will be performed with absolute values, frequencies and measures of central tendency and variability. The most appropriate tests will be used according to the type of data distribution for crossing dependent and independent variables with a 95% confidence level. The data will be presented in the form of graphs and tables.

Secondary

MeasureTime frame
Therapies (counseling, craniopuncture, low-intensity laser therapy associated with craniopuncture, biofeedback and manual therapy) will not improve in terms of functional, physical, psychological, and related to sleep and quality of life in patients diagnosed with TMD. the data will be gathered in a database created in the program Statistical Package for the Social Science (SPSS) 22.0. Descriptive analysis of the data will be performed with absolute values, frequencies and measures of central tendency and variability. The most appropriate tests will be used according to the type of data distribution for crossing dependent and independent variables with a 95% confidence level. The data will be presented in the form of graphs and tables.

Countries

Brazil

Contacts

Public ContactKaren Peixoto

Universidade Federal do Rio Grande do Norte

karenoliveirap@hotmail.com+5584991481143

Outcome results

None listed

Source: REBEC (via WHO ICTRP)